Pictet Asset Management (UK)’s Guardant Health GH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
$63.9M Buy
514,303
+264,512
+106% +$35.6M 0.07% 300
2021
Q1
$38.1M Buy
249,791
+65,750
+36% +$9.94M 0.05% 386
2020
Q4
$23.7M Sell
184,041
-33,761
-16% -$3.88M 0.03% 446
2020
Q3
$24.3M Sell
217,802
-16,885
-7% -$1.54M 0.04% 399
2020
Q2
$19M Buy
234,687
+16,770
+8% +$1.35M 0.03% 406
2020
Q1
$15.2M Buy
217,917
+38,261
+21% +$2.94M 0.03% 414
2019
Q4
$14M Buy
179,656
+36,259
+25% +$2.61M 0.02% 514
2019
Q3
$9.15M Buy
143,397
+90,708
+172% +$7.99M 0.02% 551
2019
Q2
$4.55M Buy
52,689
+26,603
+102% +$2.03M 0.01% 717
2019
Q1
$2M Buy
+26,086
New +$1.45M ﹤0.01% 859

Other funds holding GH

Pictet Asset Management (UK)'s GH Position: Q2 2021 in Review

Pictet Asset Management (UK) increased its Guardant Health (GH) stake by 106% in Q2 2021, buying an estimated $35.6M and bringing the position to 514,303 shares worth $63.9M. The position accounts for 0.07% of the portfolio, ranked #300.

Pictet Asset Management (UK) first reported a position in GH in Q1 2019 and has held it in 10 quarters since. 417 funds tracked by Wall St. Rank hold GH as of Q2 2021.

  • Pictet Asset Management (UK) held 514,303 shares of Guardant Health worth $63.9M as of Q2 2021.
  • Pictet Asset Management (UK) bought 264,512 Guardant Health shares in Q2 2021, an estimated $35.6M.
  • Guardant Health made up 0.07% of Pictet Asset Management (UK)'s portfolio in Q2 2021, its #300 holding.
  • Pictet Asset Management (UK) first reported a position in Guardant Health in Q1 2019 and has held it in 10 quarters since.
  • 417 funds tracked by Wall St. Rank held Guardant Health as of Q2 2021.

Based on Pictet Asset Management (UK)'s 13F filing for Q2 2021, filed 16 Aug 2021.